High D-dimer levels are associated with poor prognosis in cancer patients C Ay, D Dunkler, R Pirker, J Thaler, P Quehenberger, O Wagner, ... haematologica 97 (8), 1158, 2012 | 438 | 2012 |
Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients J THALER, C Ay, N Mackman, RM Bertina, A Kaider, C Marosi, NS Key, ... Journal of Thrombosis and Haemostasis 10 (7), 1363-1370, 2012 | 318 | 2012 |
Biomarkers for prediction of venous thromboembolism in cancer I Pabinger, J Thaler, C Ay Blood, The Journal of the American Society of Hematology 122 (12), 2011-2018, 2013 | 291 | 2013 |
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study C Ay, D Dunkler, R Simanek, J Thaler, S Koder, C Marosi, C Zielinski, ... J Clin Oncol 29 (15), 2099-2103, 2011 | 256 | 2011 |
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients LM Mauracher, F Posch, K Martinod, E Grilz, T Däullary, L Hell, C Brostjan, ... Journal of Thrombosis and Haemostasis 16 (3), 508-518, 2018 | 221 | 2018 |
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Ahlbrecht, B Dickmann, C Ay, D Dunkler, J Thaler, M Schmidinger, ... Journal of clinical oncology 30 (31), 3870-3875, 2012 | 198 | 2012 |
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism J Riedl, M Preusser, PMS Nazari, F Posch, S Panzer, C Marosi, P Birner, ... Blood, The Journal of the American Society of Hematology 129 (13), 1831-1839, 2017 | 193 | 2017 |
Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT) J Thaler, C Ay, KV Gleixner, AW Hauswirth, F Cacioppo, J Grafeneder, ... Journal of Thrombosis and Haemostasis 19 (7), 1819-1822, 2021 | 119 | 2021 |
Venous thromboembolism in cancer patients–risk scores and recent randomised controlled trials J Thaler, C Ay, I Pabinger Thrombosis and haemostasis 108 (12), 1042-1048, 2012 | 106 | 2012 |
Emicizumab for the treatment of acquired hemophilia A P Knoebl, J Thaler, P Jilma, P Quehenberger, K Gleixner, WR Sperr Blood, The Journal of the American Society of Hematology 137 (3), 410-419, 2021 | 104 | 2021 |
Circulating procoagulant microparticles in cancer patients J Thaler, C Ay, H Weinstabl, D Dunkler, R Simanek, R Vormittag, ... Annals of hematology 90, 447-453, 2011 | 101 | 2011 |
Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants L Wisgrill, C Lamm, J Hartmann, F Preißing, K Dragosits, A Bee, L Hell, ... Cytometry Part A 89 (7), 663-672, 2016 | 100 | 2016 |
Extracellular vesicles, tissue factor, cancer and thrombosis–discussion themes of the ISEV 2014 Educational Day C Gardiner, P Harrison, M Belting, A Böing, E Campello, BS Carter, ... Journal of extracellular vesicles 4 (1), 26901, 2015 | 96 | 2015 |
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study B Dickmann, J Ahlbrecht, C Ay, D Dunkler, J Thaler, W Scheithauer, ... haematologica 98 (8), 1309, 2013 | 96 | 2013 |
Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease S Uderhardt, JA Ackermann, T Fillep, VJ Hammond, J Willeit, P Santer, ... Journal of Experimental Medicine 214 (7), 2121-2138, 2017 | 95 | 2017 |
Microparticle‐associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features J Thaler, C Ay, N Mackman, S Metz‐Schimmerl, J Stift, A Kaider, ... European journal of clinical investigation 43 (3), 277-285, 2013 | 91 | 2013 |
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity M Mandorfer, P Schwabl, R Paternostro, K Pomej, D Bauer, J Thaler, C Ay, ... Alimentary pharmacology & therapeutics 47 (7), 980-988, 2018 | 88 | 2018 |
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients–results from the Vienna Cancer And Thrombosis Study (CATS) I Pabinger, C Ay, D Dunkler, J Thaler, EM Reitter, C Marosi, C Zielinski, ... Journal of Thrombosis and Haemostasis 13 (1), 17-22, 2015 | 87 | 2015 |
Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas J Thaler, C Ay, A Kaider, EM Reitter, J Haselböck, C Mannhalter, ... Neuro-oncology 16 (12), 1645-1651, 2014 | 81 | 2014 |
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients J Thaler, M Preusser, C Ay, A Kaider, C Marosi, C Zielinski, I Pabinger, ... Thrombosis research 131 (2), 162-165, 2013 | 79 | 2013 |